Developing the Next Generation Total Artificial Heart System

Founded in January 2014, OregonHeart is an early stage pre-clinical implantable medical device company. Our mission is to provide end-stage heart failure patients with a longer and more quality life. We are successfully executing on this mission by following a highly focused, capital efficient, and accelerated roadmap to deliver a next generation Total Artificial Heart System (TAHS) to clinicians and patients. OregonHeart’s TAHS will provide a medical solution for a significant number of patients for whom no appropriate therapy, device, nor donor heart currently exists.